CVE-2022-26240

MEDIUM 6.5CVE-2022-26240 · Published 06/10/2022 · updated 17/06/2026

In short

CVE-2022-26240 is a MEDIUM (CVSS 6.5) vulnerability affecting remisol advance (beckmancoulter).
Chance of exploitation in the next 30 days (EPSS): 0.71%, higher than 53.7% of all vulnerabilities.
No patched version is listed yet: follow the vendor's advisory in References.

Package	Affected versions	Patched versions
remisol advance beckmancoulter	`≤ 2.0.12.1`	No fix yet

Description

The default privileges for the running service Normand Message Buffer in Beckman Coulter Remisol Advance v2.0.12.1 and prior allows non-privileged users to overwrite and manipulate executables and libraries. This allows attackers to access sensitive data.

References

pastebin.com/Bsy6KTxJ · Third Party Advisory
beckmancoulter.com/products/clinical-information-management-tools/remisol-advance · Product

More vulnerabilities in remisol advance

See all →

Running one of these products? Scan your site to see whether it exposes a vulnerable version.

Scan my site free

Package

Affected versions

Patched versions

remisol advance

beckmancoulter

≤ 2.0.12.1

No fix yet

More vulnerabilities in remisol advance

See all →